| Predictors of shoulder dystocia at the time of operative vaginal delivery A Palatnik, WA Grobman, MG Hellendag, TM Janetos, DR Gossett, ... American journal of obstetrics and gynecology 215 (5), 624. e1-624. e5, 2016 | 34 | 2016 |
| Time for a makeover‐cosmetics regulation in the United States EM Cornell, TM Janetos, S Xu Journal of Cosmetic Dermatology 18 (6), 2041-2047, 2019 | 30 | 2019 |
| Predictors of failed operative vaginal delivery in a contemporary obstetric cohort A Palatnik, WA Grobman, MG Hellendag, TM Janetos, DR Gossett, ... Obstetrics & Gynecology 127 (3), 501-506, 2016 | 26 | 2016 |
| Overview of high‐risk Food and Drug Administration recalls for cosmetics and personal care products from 2002 to 2016 TM Janetos, L Akintilo, S Xu Journal of Cosmetic Dermatology 18 (5), 1361-1365, 2019 | 15 | 2019 |
| Approval-adjusted recall rates of high-risk medical devices from 2002-2016 across Food and Drug Administration device categories CW Ghobadi, TM Janetos, S Tsai, JL Beaumont, L Welty, JR Walter, S Xu Issues L. & Med. 34, 77, 2019 | 9 | 2019 |
| Geographic and provider variations in ocular hypotensive medication claims among Medicare part D enrollees TM Janetos, DD French, JL Beaumont, AP Tanna Journal of Glaucoma 28 (2), e29-e33, 2019 | 7 | 2019 |
| Overview of high-risk medical device recalls in obstetrics and gynecology from 2002 through 2016: implications for device safety TM Janetos, CW Ghobadi, S Xu, JR Walter American journal of obstetrics and gynecology 217 (1), 42-46. e1, 2017 | 7 | 2017 |
| Ocular Cosmetics: Public Safety Problem or Harmless Products? TM Janetos, P Thyparampil Ophthalmic Plastic & Reconstructive Surgery 35 (3), 294-295, 2019 | 5 | 2019 |
| Pharmacologic mydriasis secondary to topical glycopyrronium tosylate cloths: clinical characterization from a multicenter analysis AR Kaufman, S Gulati, JH Pula, TM Janetos, NR Cherayil, E Chiu, ... Journal of Neuro-Ophthalmology 42 (4), 530-534, 2022 | 4 | 2022 |
| Neuro-ophthalmic manifestations of cancer: a narrative review TM Janetos, NJ Volpe, SS Simon Chinese clinical oncology 11 (3), 25-25, 2022 | 3 | 2022 |
| Reducing FDA regulations for medical devices: cutting red tape or putting patients’ lives at risk? TM Janetos, RS Xu, JR Walter, S Xu Expert Review of Medical Devices 15 (12), 859-861, 2018 | 3 | 2018 |
| The microbiome and uveitis: a narrative review TM Janetos, N Zakaria, DA Goldstein The American Journal of Pathology, 2023 | 2 | 2023 |
| Photocoagulation of Transudative Type 2 Retinal Arteriovenous Malformation T Janetos, MV Cicinelli, RG Mirza, LM Jampol JAMA ophthalmology 139 (7), 805-807, 2021 | 2 | 2021 |
| Retinal detachment and laser retinopexy rates during the COVID-19 pandemic TM Janetos, AN Hall, MK Gill Journal of VitreoRetinal Diseases 5 (4), 295-297, 2021 | 2 | 2021 |
| Regulation of cosmetics TM Janetos, M Kwa, S Xu JAMA internal medicine 178 (7), 1000-1001, 2018 | 2 | 2018 |
| Tubulointerstitial nephritis and uveitis syndrome in pediatric patients TM Janetos, PHA Lee, DA Goldstein Ocular Immunology and Inflammation 31 (10), 1955-1964, 2023 | 1 | 2023 |
| Cranial Nerve Palsies in the Setting of Arachnoid Cysts: A Case Series and Literature Review HS Bison, TM Janetos, EJ Russell, NJ Volpe Journal of Neuro-Ophthalmology, 10.1097, 2022 | 1 | 2022 |
| Ophthalmic drug discovery in the United States over the past two decades D Gu, TM Janetos Ophthalmic Epidemiology 28 (1), 21-26, 2021 | 1 | 2021 |
| The Humira in Ocular Inflammations Taper (HOT) Study F Pichi, SD Smith, DA Goldstein, D Baddar, TKA Gerges, TM Janetos, ... American journal of ophthalmology 258, 87-98, 2024 | | 2024 |
| Long-Term Clinical Outcomes of the 0.18 Mg Fluocinolone Acetonide Intravitreal Implant Following Local Corticosteroid Burst in Noninfectious Uveitis TM Janetos, A Koreishi, DA Goldstein Ocular Immunology and Inflammation, 1-6, 2024 | | 2024 |
